| Document |
Document Title |
|
WO/2016/002918A1 |
Provided is a novel method for producing an indole compound or salt thereof having an ITK-inhibiting effect and being useful in the treatment or prevention of inflammatory diseases and the like. A method for producing N-[2-(6,6-dimethyl-...
|
|
WO/2015/190118A1 |
The present invention relates to an onium salt, an acrylic acid copolymer containing the onium salt, and an antistatic agent containing the onium salt or the acrylic acid copolymer.　The present invention provides an onium salt capable ...
|
|
WO/2015/165352A1 |
The present invention provides a compound with a structure represented by general formula I or a pharmaceutically acceptable salt thereof, a preparation method for the compound or the salt, and a use of the compound or the pharmaceutical...
|
|
WO/2015/158799A1 |
The invention relates to a process for preparing alkylaryl carbamates from alkyl formates and at least one amino aryl compound in the presence of a metal-based catalyst. The alkylaryl carbamates can be used for the preparation of isocyan...
|
|
WO/2015/151885A1 |
Provided is a fluorine-containing monomer, which can be solubilized in a hydrocarbon solvent and also has excellent water and oil repellence, and a manufacturing method therefor. A carboxylic ester / carbamate compound, which is represen...
|
|
WO/2015/152221A1 |
[Problem] To provide a polymerizable monomer for dental material with which a hardened material having both the properties of high toughness and rigidity can be achieved, and also provide a polymerizable monomer composition for dental ma...
|
|
WO/2015/146905A1 |
[Problem] To provide: an acrylic or methacrylic compound having an N-alkoxyalkyl group; and a method for producing the acrylic or methacrylic compound. [Solution] An acrylic or methacrylic compound which is represented by formula (1) and...
|
|
WO/2015/132801A1 |
The present invention discloses a process for the synthesis of dimethyl carbonate (DMC) and further methyl-N-methyl carbamate (MNMC) starting from urea or methyl carbamate using salts such as nitrate or triflate salts of rare earth eleme...
|
|
WO/2015/133247A1 |
Provided is an industrially advantageous carbamic acid ester production method whereby it becomes possible to produce a carbamic acid ester, such as an aromatic carbamic acid ester, with high yield and high selectivity without requiring ...
|
|
WO/2015/130121A1 |
The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound.
|
|
WO/2015/127556A1 |
Compositions for eliciting acute defecation in subjects having a spinal cord injury (SCI subject) are described herein. The compositions may generally comprise one or more of a 5-HT (5-hydroxytryptamine, serotonin) receptor agonist, a be...
|
|
WO/2015/127559A1 |
The present disclosure relates to compounds of formula I : compositions containing same and methods for treating or preventing a condition associated with brown adipose tissue dysfunction in a subject and/or for converting white adipose ...
|
|
WO/2015/127558A1 |
Compositions for eliciting acute micturition (voiding activity) in subjects having a spinal cord injury (SCI subject) are described herein. The compositions may generally comprise one or more of a 5-HT (5-hydroxytryptamine, serotonin) re...
|
|
WO/2015/122494A1 |
Provided is a novel compound having an excellent suppression action against arrhythmia including atrial fibrillation and being useful as a pharmaceutical product having a separated antiviral effect. A compound indicated by general formul...
|
|
WO/2015/123416A1 |
A method of producing a polycarbodiimide polymer comprises heating a precursor compound at a desired temperature. The method further comprises combining the precursor compound, a diisocyanate compound, and a carbodiimidization catalyst t...
|
|
WO/2015/117146A1 |
β-Substituted -amino acids, β-substituted γ-amino acid derivatives, and β-substituted γ-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted γ-amino acid derivatives and Î...
|
|
WO/2015/115650A1 |
Provided is a method for producing an optically active carboxylic acid ester at a high yield and with high enantioselectivity using dynamic kinetic resolution, said optically active carboxylic acid ester having an α-nitrogen substituent...
|
|
WO/2015/116786A1 |
In one aspect, the invention relates to compounds having the formula (I): where R1-R6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another asp...
|
|
WO/2015/117147A1 |
β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and...
|
|
WO/2015/109935A1 |
The invention generally relates to compounds of formula (I) with neural protective effect, and preparation and uses thereof. The compounds have multiple mechanisms or functions, for example, inhibition of monoamine oxidase and cholineste...
|
|
WO/2015/109666A1 |
Disclosed are an ester group-containing aromatic propionamide compound, and a preparation method therefor and uses thereof, and provides a chemical structure formula of the new ester group-containing aromatic propionamide compound. The c...
|
|
WO/2015/107064A1 |
The present invention relates to methods for linking tetrazines with dienophiles to establish at least two linkages by sequentially performing at least two cycloaddition reactions. The methods in particular allow establishing multi-label...
|
|
WO/2015/093469A1 |
The present invention involves preparing compounds represented by the formula. (In the formula: R1 represents a Br group, an iodine group, a Cl group, an NO2 group, or an NH2 group; R2 represents a halogen group, an NO2 group, an NH2 gro...
|
|
WO/2015/087341A1 |
The present invention relates to an improved process for the preparation of dimethyl carbonate and methyl-N-methyl carbamate starting from methanol and methyl carbamate catalyzed by ionic liquid catalyst in batch or continuous reactor.
|
|
WO/2015/077451A1 |
The present invention relates to N-phenyl carbamate derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide 2 receptor.
|
|
WO/2015/076346A1 |
An optically active 2,6-dimethyltyrosine derivative represented by formula (1) (wherein R1 represents a hydrogen atom or a protecting group for a phenol group; R2 represents a protecting group for an amino group; and * represents an asym...
|
|
WO/2015/075744A1 |
The present invention relates to novel carbamate intermediate of formula (II), process for its preparation and process for its conversion into 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol, tapentadol and its pharmaceuticall...
|
|
WO/2015/074085A1 |
What is described is a compound of formula (I), wherein R1 and R2 are the same or different, each a linear or branched alkyl with 1-9 carbons, or an alkenyl or alkynyl with 2 to 11 carbon atoms; L1 and L2 are the same or different, each ...
|
|
WO/2015/060359A1 |
Provided are a novel diamine, and a polyimide precursor and polyimide using the same. A diamine represented by formula (1). (In formula (1), X1 and X5 each independently represents a single bond or the like, X2 and X4 each independently ...
|
|
WO/2015/055447A1 |
The present invention relates to a process for preparing substituted isatoic acid anhydride compounds of the formula (I) in which R1 is Cl, Br, I, or CN; and R2 is CH3, Cl, Br; using anthranilic acid derivative compounds of formula (III)...
|
|
WO/2015/054476A1 |
Methods of halogenating a carbon containing compound having an sp3 C-H bond are provided. Methods of fluorinating a carbon containing compound comprising halogenation with Cl or Br followed by nucleophilic substitution with F are provide...
|
|
WO/2015/039172A1 |
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
|
|
WO/2015/036550A1 |
The invention relates to an improved process and novel intermediates (4) and (6) for the preparation of pharmaceutically active compound etoricoxib of formula (1).
|
|
WO/2015/037460A1 |
Optically active 3-(biphenyl-4-yl)-2-[(t-butoxycarbonyl)amino]propan-1-ol can be produced through: a step of reacting an optically active biphenylalanine compound represented by formula [I] with a reducing agent to produce an optically a...
|
|
WO/2015/032939A1 |
A solid catalyst component for the polymerization of olefins comprising Mg, Ti and an electron donor of formula (I), where R1 is selected from C1-C15 hydrocarbon groups, R2 groups, equal to or different from each other, are hydrogen or R...
|
|
WO/2015/032357A1 |
Zanamivir, a Zanamivir intermediate compound (formula 2), and a preparation method therefor. The preparation method is method 1 or 2. Method 1 comprises the following steps: compound 3 undergoes a reaction to remove a protecting group so...
|
|
WO/2015/030106A1 |
The present invention relates to compounds represented by general formula (I) (where Z, R, Ra, R', * and n are each as defined in the description) or salts thereof.
|
|
WO/2015/025960A1 |
Provided are: a compound having high activity against harmful organisms; a harmful organism control agent comprising the compound; and a method for controlling harmful organisms by applying the compound. A phenoxyalkylbenzamide-type comp...
|
|
WO/2015/025773A1 |
This method for producing an m-xylylene diisocyanate contains: a reaction step for generating a bisamide compound by reacting, in the presence of an acidic liquid, a monohalogenated benzene, formaldehyde, and an amide compound indicated ...
|
|
WO/2015/025826A1 |
The purpose of the present invention is to provide: a novel substituted phenyl ether compound which has a control effect against pests; and a pest control agent which contains this substituted phenyl ether compound as an active ingredien...
|
|
WO/2015/024991A1 |
The invention relates to a novel synthesis route towards R- biphenylalaninol and to the intermediates applied in this synthesis route. The process according to the invention and the intermediate compounds are useful in the synthesis of p...
|
|
WO/2015/016263A1 |
The present invention relates to a reaction method having a step for supplying a liquid including at least one species of a raw material compound and a low-boiling compound having a standard boiling point lower than the standard boiling ...
|
|
WO/2015/010436A1 |
Disclosed is a new Carfilzomib intermediate and a preparation method therefor, and a preparation method for Carfilzomib using the intermediate. The Carfilzomib intermediate provided by the invention is easily separated from the isomers t...
|
|
WO/2015/012407A1 |
The present invention pertains to a cellulose acylate film containing a compound having at least one linking group selected from the group consisting of a bivalent linking group represented by -NH-(C=O)-O- and a bivalent linking group re...
|
|
WO/2015/012258A1 |
A composition including: a polymerizable compound (A) having a (meth) acryloyl group and an isocyanate group in each molecule; and a reaction accelerator (B) comprising a compound having a (meth) acryloyl group and a carbamoyl halide gro...
|
|
WO/2015/012259A1 |
Provided is a reaction accelerator used in a reaction between a compound having an isocyanate group that does not directly bond to an aromatic ring, in each molecule, and a compound having an active hydrogren-containing group. The reacti...
|
|
WO/2015/010014A1 |
The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further r...
|
|
WO/2015/007897A1 |
The present invention provides a very simple, efficient and economic technology for racemisation of amines, alcohols or thioalcohols where the chiral carbon (benzylic position) is located at the β-position of the heteroatom (amino, hydr...
|
|
WO/2015/006685A1 |
The present invention relates to a method for promoting cessation or reduction in the smoking and/or chewing of tobacco or nicotine-containing products in a subject in need thereof, comprising administering to the subject an effective am...
|
|
WO/2014/207071A1 |
The present invention relates to novel strobilurine type compounds, to compositions comprising at least one such compound, to methods for combating phytopathogenic fungi, to the use of such compounds and to seeds coated with at least one...
|
